# BreatheAmerica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/breatheamerica

- Industry: Travel & Leisure
- Headquarters: Nashville, US
- Website: www.breatheamerica.com
- Total disclosed funding: $22M
- Latest round: Series B (Sep 6, 2011)
- Investors on record: 1

## About

BreatheAmerica focuses on comprehensive treatment solutions for allergy, asthma, and sinus conditions, promoting airway health through personalized patient care.Founded in 2006 and headquartered in Nashville, US, BreatheAmerica specializes in respiratory health. The company has completed 3 deals, with its most recent funding round occurring on September 25, 2013, where it raised USD 2.8 mn in VENTURE DEBT. BreatheAmerica has raised a total of USD 5.00 mn. The current CEO is Joseph Hutts.BreatheAmerica specializes in comprehensive allergy, asthma, and sinus treatment, providing a holistic approach to airway health. The company operates treatment centers that offer personalized diagnoses and tailored treatment plans, addressing interrelated conditions that affect respiratory health. Their core services include management and treatment of allergies, chronic asthma, and sinusitis, along with advanced infusion therapy for patients requiring ongoing medication administration. BreatheAmerica serves a diverse client base, including individuals suffering from chronic respiratory conditions, families seeking allergy management for children, and patients requiring specialized medical attention in New Mexico and Louisiana. The company’s services are designed to streamline patient care by centralizing treatment within a single facility, enhancing convenience and patient outcomes.BreatheAmerica generates revenue primarily through direct-to-consumer services, where patients pay for consultations, diagnostic assessments, and treatment plans on a fee-for-service basis. The business model includes one-time visits for initial evaluations as well as ongoing treatment sessions that may be bundled into comprehensive care packages. Specialty services, such as infusion therapy, contribute to revenue streams through both individual payments and potential partnerships with healthcare providers. The pricing structure for consultations and treatments is established to reflect the high-quality, hospital-level care provided in a more personalized setting. BreatheAmerica's offerings focus on delivering significant health improvements, which can lead to recurring patient engagement and loyalty, reinforcing the financial sustainability of its model.BreatheAmerica is planning to expand its services by introducing new treatment options targeting additional respiratory conditions. The company aims to enter new markets, specifically focusing on areas in the Southeastern US by the end of 2024. The recent funding of USD 2.8 mn will be allocated to support these initiatives, enhancing their operational capabilities and market reach.

## Funding rounds

- Series B, Sep 6, 2011, $22M — Essex Woodlands

## Investors

- Essex Woodlands (https://capitalatlas.ai/funds/essex-woodlands) — Series B